Startup Overview:

TrialSpark

TrialSpark is a clinical trial management software and drug development company. The company aims to accelerate the pace of clinical trials and bring down costs with a software platform that helps sites like hospitals manage trials and collect and analyze data. Per the company, it uses data from social media to find doctors and patients to participate.While it began as a clinical trial technology platform, in 2021, it signaled a move to using its technology for drug development through the acquisition of biologic and small-molecule drugs. TrialSpark began primarily as a technology company that aims to bring treatments to patients faster using technology that improves clinical trials and drug development. TrialSpark has scaled a network of trial sites by partnering with doctors to create clinical trial sites within their existing practices. TrialSpark runs trials out of these doctor practices using a roaming cohort of certified research coordinators, optimized by software, data, and technology. Without variability in operations at the trial site level, TrialSpark cuts out the manual, time-intensive, and costly tasks that delay clinical trial timelines. By creating trial sites with doctors, TrialSpark unlocks the 98 percent of patients who have never been exposed to trials, boosting recruitment and enrollment rates and democratizing access.

TrialSpark
Valuation
$
1
Billion
Country
United States
City
New York
Industry
Health
Website
Valuation
$
1
Billion
Country
United States
City
New York
Industry
Health
Website

Sign-up for our free weekly newsletter to get regular updates when new startups are added.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.